Literature DB >> 31434721

Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.

Sohei Harada1,2,3, Kotaro Aoki2, Shungo Yamamoto4, Yoshikazu Ishii2, Noritaka Sekiya5, Hanako Kurai6, Keiichi Furukawa7, Asako Doi8, Kentaro Tochitani4, Kenji Kubo9, Yukihiro Yamaguchi10, Masashi Narita11,12, Shinya Kamiyama13, Jun Suzuki14, Takahiko Fukuchi15, Yoshiaki Gu16, Keiji Okinaka17, Soichi Shiiki12, Kayoko Hayakawa18, Natsuo Tachikawa19, Kei Kasahara20, Tadahiro Nakamura21, Kyoko Yokota22,23, Masanari Komatsu24, Misaki Takamiya25, Kazuhiro Tateda2, Yohei Doi26.   

Abstract

Although hypervirulent Klebsiella pneumoniae (hvKp) has been associated with severe community-acquired infections that occur among relatively healthy individuals, information about hvKp infections in health care settings remains limited. Here, we systematically analyzed the clinical and molecular characteristics of K. pneumoniae isolates causing bloodstream infections in a cross-sectional study. Clinical characteristics of K. pneumoniae bloodstream infections from hospitals across Japan were analyzed by a review of the medical records. Whole-genome sequencing of the causative isolates was performed. Bacterial species were confirmed and hvKp were identified using whole-genome sequencing data. Clinical characteristics of hvKp infections were compared with those of non-hvKp infections by bivariate analyses. Of 140 cases of K. pneumoniae bloodstream infections, 26 cases (18.6%) were caused by various clones of hvKp defined by the carriage of cardinal virulence genes. Molecular identification revealed that 24 (17.1%) and 14 (10%) cases were caused by Klebsiella variicola and Klebsiella quasipneumoniae, respectively. Patients with hvKp infections had higher proportions of diabetes mellitus (risk ratio [RR], 1.75; 95% confidence interval [CI], 1.05 to 2.94), and their infections had significantly higher propensity to involve pneumonia (RR, 5.85; 95% CI, 1.39 to 24.6), liver abscess (RR, 5.85; 95% CI, 1.39 to 24.6), and disseminated infections (RR, 6.58; 95% CI, 1.16 to 37.4) than infections by other isolates. More than one-half of hvKp infections were health care associated or hospital acquired, and a probable event of health care-associated transmission of hvKp was documented. hvKp isolates, which are significantly associated with severe and disseminated infections, are frequently involved in health care-associated and hospital-acquired infections in Japan.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  bloodstream infection; disseminated infection; hypervirulent Klebsiella pneumoniae; whole-genome sequencing

Mesh:

Substances:

Year:  2019        PMID: 31434721      PMCID: PMC6812994          DOI: 10.1128/JCM.01206-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France.

Authors:  Dominique Decré; Charlotte Verdet; Aurélie Emirian; Thibault Le Gourrierec; Jean-Claude Petit; Georges Offenstadt; Eric Maury; Sylvain Brisse; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2011-06-15       Impact factor: 5.948

2.  The comprehensive antibiotic resistance database.

Authors:  Andrew G McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A Azad; Alison J Baylay; Kirandeep Bhullar; Marc J Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M King; Kalinka Koteva; Mariya Morar; Michael R Mulvey; Jonathan S O'Brien; Andrew C Pawlowski; Laura J V Piddock; Peter Spanogiannopoulos; Arlene D Sutherland; Irene Tang; Patricia L Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.

Authors:  N Deborah Friedman; Keith S Kaye; Jason E Stout; Sarah A McGarry; Sharon L Trivette; Jane P Briggs; Wanda Lamm; Connie Clark; Jennifer MacFarquhar; Aaron L Walton; L Barth Reller; Daniel J Sexton
Journal:  Ann Intern Med       Date:  2002-11-19       Impact factor: 25.391

5.  The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited.

Authors:  Chun-Ru Hsu; Tzu-Lung Lin; You-Ci Chen; Huei-Chi Chou; Jin-Town Wang
Journal:  Microbiology       Date:  2011-09-29       Impact factor: 2.777

6.  Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess.

Authors:  Yi-Ping Chuang; Chi-Tai Fang; Shau-Yan Lai; Shan-Chwen Chang; Jin-Town Wang
Journal:  J Infect Dis       Date:  2006-01-20       Impact factor: 5.226

Review 7.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

8.  Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.

Authors:  Carsten Struve; Chandler C Roe; Marc Stegger; Steen G Stahlhut; Dennis S Hansen; David M Engelthaler; Paal S Andersen; Elizabeth M Driebe; Paul Keim; Karen A Krogfelt
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

9.  Bacterial Meningitis Caused by Hypervirulent Klebsiella pneumoniae Capsular Genotype K54 with Development of Granuloma-like Nodal Enhancement in the Brain during the Subacute Phase.

Authors:  Yudai Iwasaki; Ryota Inokuchi; Sohei Harada; Kotaro Aoki; Yoshikazu Ishii; Kazuaki Shinohara
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

10.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more
  23 in total

Review 1.  Innate Host Defense against Klebsiella pneumoniae and the Outlook for Development of Immunotherapies.

Authors:  Clement Opoku-Temeng; Natalia Malachowa; Scott D Kobayashi; Frank R DeLeo
Journal:  J Innate Immun       Date:  2021-10-08       Impact factor: 7.111

2.  Development of risk factor-based scoring system for detection of hypervirulent Klebsiella pneumoniae bloodstream infections.

Authors:  Michinobu Yoshimura; Chiemi Tokushige; Atsushi Togawa; Akira Matsunaga; Tohru Takata; Yasushi Takamatsu
Journal:  Gut Pathog       Date:  2020-07-09       Impact factor: 4.181

3.  SKAP2 is required for defense against K. pneumoniae infection and neutrophil respiratory burst.

Authors:  Giang T Nguyen; Lamyaa Shaban; Matthias Mack; Kenneth D Swanson; Stephen C Bunnell; David B Sykes; Joan Mecsas
Journal:  Elife       Date:  2020-04-30       Impact factor: 8.140

4.  The Galleria mellonella Infection Model Does Not Accurately Differentiate between Hypervirulent and Classical Klebsiella pneumoniae.

Authors:  Thomas A Russo; Ulrike MacDonald
Journal:  mSphere       Date:  2020-01-08       Impact factor: 4.389

5.  COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020.

Authors:  Tomohiro Hosoda; Sohei Harada; Koh Okamoto; Sumire Ishino; Makoto Kaneko; Masahiro Suzuki; Ryota Ito; Miyuki Mizoguchi
Journal:  Emerg Infect Dis       Date:  2020-12-15       Impact factor: 6.883

6.  Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes.

Authors:  Youhua Yuan; Junjie Wang; Zonghui Yao; Bing Ma; Yi Li; Wenjuan Yan; Shanmei Wang; Qiong Ma; Jiangfeng Zhang; Junhong Xu; Li Li; Yuming Wang; Enguo Fan
Journal:  Infect Drug Resist       Date:  2020-01-22       Impact factor: 4.003

7.  Hypervirulent Klebsiella pneumoniae is emerging as an increasingly prevalent K. pneumoniae pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China.

Authors:  Chao Liu; Pengcheng Du; Nan Xiao; Fansen Ji; Thomas A Russo; Jun Guo
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

8.  Characterization and Full Genome Sequence of Novel KPP-5 Lytic Phage against Klebsiella pneumoniae Responsible for Recalcitrant Infection.

Authors:  Ahmed R Sofy; Noha K El-Dougdoug; Ehab E Refaey; Rehab A Dawoud; Ahmed A Hmed
Journal:  Biomedicines       Date:  2021-03-28

Review 9.  Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae.

Authors:  Subhankar Mukherjee; Shravani Mitra; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2021-06-11

10.  Ruptured Emphysematous Prostatic Abscess Caused by K1-ST23 Hypervirulent Klebsiella pneumoniae Presenting as Brain Abscesses: A Case Report and Literature Review.

Authors:  Kensuke Konagaya; Hiroyuki Yamamoto; Tomoyuki Suda; Yusuke Tsuda; Jun Isogai; Hiroyuki Murayama; Yoshichika Arakawa; Hidemitsu Ogino
Journal:  Front Med (Lausanne)       Date:  2022-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.